Sana biotechnology to present at the goldman sachs 42nd annual global healthcare conference

Seattle, june 02, 2021 (globe newswire) -- sana biotechnology, inc. (nasdaq: sana), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast its presentation at the goldman sachs 42nd annual global healthcare conference at 12:00 p.m. pt on wednesday, june 9, 2021. the presentation will feature a business overview and update by steve harr, sana's president and chief executive officer.
SANA Ratings Summary
SANA Quant Ranking